Drugs that inhibit specific kinases are being developed to treat several diseases, and some are currently in clinical use, including Gleevec (imatinib) and Iressa (gefitinib).
Estanse desenvolvendo fármacos que inhiben quinases específicas para tratar varias doenzas, e algunhas están actualmente en uso clínico, como o Gleevec (imatinib) e Iressa (gefitinib).